Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manja Idorn

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Antiviral Research|November 28, 2020
Ionophore antibiotic X-206 is a potent inhibitor of SARS-CoV-2 infection in vitroEsben B Svenningsen, Jacob Thyrsted, Julia Blay-Cadanet, et al.
Scandinavian Cardiovascular Journal : SCJ|September 12, 2015
Influence of acute glycaemic level on measures of myocardial infarction in non-diabetic pigsSarah S Diemar, Anne-Sophie Sejling, Kasper K Iversen, et al.
Elife|November 25, 2021
The alpha/B.1.1.7 SARS-CoV-2 variant exhibits significantly higher affinity for ACE-2 and requires lower inoculation doses to cause disease in K18-hACE2 miceRafael Bayarri-Olmos, Laust Bruun Johnsen, Manja Idorn, et al.
The Journal of Allergy and Clinical Immunology|August 21, 2018
Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivityCaroline B K Mathiesen, Michael C Carlsson, Stephanie Brand, et al.
Cell Metabolism|February 21, 2016
Voluntary Running Suppresses Tumor Growth through Epinephrine- and IL-6-Dependent NK Cell Mobilization and RedistributionLine Pedersen, Manja Idorn, Gitte H Olofsson, et al.
Frontiers in Immunology|April 28, 2022
A Capsid Virus-Like Particle-Based SARS-CoV-2 Vaccine Induces High Levels of Antibodies and Protects Rhesus MacaquesAriane Volkmann, Gerrit Koopman, Petra Mooij, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 8, 2021
A serum-stable RNA aptamer specific for SARS-CoV-2 neutralizes viral entryJulián Valero, Laia Civit, Daniel M Dupont, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 24, 2021
SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding DomainRafael Bayarri-Olmos, Manja Idorn, Anne Rosbjerg, et al.
EMBO Reports|October 21, 2022
Human ZBP1 induces cell death-independent inflammatory signaling via RIPK3 and RIPK1Ruoshi Peng, Chris Kedong Wang, Xuan Wang-Kan, et al.
Communications Biology|October 1, 2024
Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineagesMelanie R Walker, Alexander Underwood, Kasper H Björnsson, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Antiviral Research|November 28, 2020
Ionophore antibiotic X-206 is a potent inhibitor of SARS-CoV-2 infection in vitroEsben B Svenningsen, Jacob Thyrsted, Julia Blay-Cadanet, et al.
Scandinavian Cardiovascular Journal : SCJ|September 12, 2015
Influence of acute glycaemic level on measures of myocardial infarction in non-diabetic pigsSarah S Diemar, Anne-Sophie Sejling, Kasper K Iversen, et al.
Elife|November 25, 2021
The alpha/B.1.1.7 SARS-CoV-2 variant exhibits significantly higher affinity for ACE-2 and requires lower inoculation doses to cause disease in K18-hACE2 miceRafael Bayarri-Olmos, Laust Bruun Johnsen, Manja Idorn, et al.
The Journal of Allergy and Clinical Immunology|August 21, 2018
Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivityCaroline B K Mathiesen, Michael C Carlsson, Stephanie Brand, et al.
Cell Metabolism|February 21, 2016
Voluntary Running Suppresses Tumor Growth through Epinephrine- and IL-6-Dependent NK Cell Mobilization and RedistributionLine Pedersen, Manja Idorn, Gitte H Olofsson, et al.
Frontiers in Immunology|April 28, 2022
A Capsid Virus-Like Particle-Based SARS-CoV-2 Vaccine Induces High Levels of Antibodies and Protects Rhesus MacaquesAriane Volkmann, Gerrit Koopman, Petra Mooij, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 8, 2021
A serum-stable RNA aptamer specific for SARS-CoV-2 neutralizes viral entryJulián Valero, Laia Civit, Daniel M Dupont, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 24, 2021
SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding DomainRafael Bayarri-Olmos, Manja Idorn, Anne Rosbjerg, et al.
EMBO Reports|October 21, 2022
Human ZBP1 induces cell death-independent inflammatory signaling via RIPK3 and RIPK1Ruoshi Peng, Chris Kedong Wang, Xuan Wang-Kan, et al.
Communications Biology|October 1, 2024
Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineagesMelanie R Walker, Alexander Underwood, Kasper H Björnsson, et al.
Pageof 5